(May 17, 2019, 2:22 PM EDT) -- PHILADELPHIA — In a split ruling, the Third Circuit U.S. Court of Appeals on May 15 reversed a district court’s denial of a motion to unseal underlying documents created by GlaxoSmithKline LLC (GKS) in the Avandia multidistrict litigation and remanded for application of the common-law right of access and for a document-by-document review (In Re: Avandia Marketing, Sales Practices and Products Liability Litigation [United Food and Commercial Workers Local 1776, et al.], Nos. 18-2259 and 18-2656, 3rd Cir., 2019 U.S. App. LEXIS 14470)....